Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80
Document › Details

3P Biopharmaceuticals S.L.. (5/5/15). "Press Release: 3P Biopharmaceuticals Acquires a Mass Spectrometer".

Organisations Organisation 3P Biopharmaceuticals S.L.
  Organisation 2 Waters Corporation (NYSE: WAT)
  Group Waters (Group)
Product Product  mass spectrometry-based analysis of biopharmaceutical
Index term Index term Infarco–Waters: mass spectrometer, 201505 supply acquisition of Xevo G2-XS QTof MS system by 3PBio

We have recently added a mass spectrometer to our pipeline equipment: a device that allows the measurement of the internal mass of proteins and the determination of their peptide fingerprint, ensuring a deeper characterization of new processes.

This significant economic and technological investment is a very important qualitative leap for 3P since it will mean reaching adequate capacity for characterizing the structure of proteins developed in their processes.

In addition, this significant investment in technology, along with others that we will make in the next few months, sets us apart in terms of our internal capabilities. In maintaining control over our activities by keeping them on our own premises, we provide our clients a differential value in the development and production services we offer by minimizing outsourcing that result in increased costs and production time, and in a loss of control over processes and knowledge of molecules.

Record changed: 2016-06-07


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for 3P Biopharmaceuticals S.L.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top